Clinical Trials Logo

Brain Injuries clinical trials

View clinical trials related to Brain Injuries.

Filter by:

NCT ID: NCT05182619 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Stellate Block Versus Nimodipine Infusion for Traumatic Brain Injury

Start date: January 1, 2022
Phase: Early Phase 1
Study type: Interventional

the study is designed to perform an intervention for enhancement of cerebral blood flow in patients with traumatic brain injury showing vasospasm through transcranial doppler

NCT ID: NCT05179330 Completed - Brain Injuries Clinical Trials

Visual Feedback in Lower Limb Rehabilitation

Start date: October 13, 2020
Phase: N/A
Study type: Interventional

Severe Acquired Brain Injury (sABI) is defined as "an encephalic impairment that occurs after birth and is not related to a congenital or degenerative disease. This impairment may be temporary, or permanent, and cause partial or functional disability or psychosocial distress." In Italy there are at least 10-15 new cases of sABI per year per 100,000 inhabitants; the estimated prevalence is about 150,000 cases per year. Often, people with sABI present focal neurological deficits, including alterations in strength, sensitivity, coordination and gait. Most of the rehabilitation protocols for people with sABI are derived from post-stroke studies, caused by lack of evidence on specific rehabilitation of people with sABI. Rehabilitation of people with sABI should begin as soon as possible, to prevent the onset of retractions and decubitus, and to regain joint mobility, strength, and coordination. OMEGO® (Tyromotion) is a newly developed device used in lower extremity rehabilitation, that provides visual and auditory feedback. Specifically, OMEGO® contains several games developed to enhance and promote learning behaviors, that simulate activities of daily living. The use of devices such as cycle ergometers is recommended in the rehabilitation of people with sABI; however, there are no studies demonstrating the effect of cycle ergometer training in association with visual feedback. The purpose of this study is to evaluate, both in people without apparent pathology (hereafter identified as "healthy") and in people with sABI, whether visual feedback during OMEGO® exercise modifies brain connectivity, emotional drive, and lower limb performance during a lower limb-specific motor rehabilitation task.

NCT ID: NCT05176392 Recruiting - Depression Clinical Trials

Combined Transcranial Magnetic Stimulation and Therapy for mTBI Related Headaches

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.

NCT ID: NCT05171699 Recruiting - Sepsis Clinical Trials

Effect of Electroacupuncture in Patients With Sepsis Associated Brain Injury

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

To investigate the effect of electroacupuncture on patients with sepsis-associated brain injury.

NCT ID: NCT05171010 Completed - Clinical trials for Traumatic Brain Injury

Geri-TBI: A Prospective Multi-center Evaluation of Geriatric Patients With Traumatic Brain Injury

Start date: November 29, 2017
Phase:
Study type: Observational

This multicenter prospective observational study is designed to prospectively record data on patients who are managed per institutional standard of care. The objectives of this study are to establish an aggregate database of information on baseline clinical and demographic characteristics, medication use, markers of frailty, injury characteristics, management strategies, and outcomes following TBI in geriatric patients, determine best practices for management of geriatric patients with TBI, and establish how markers of frailty correlate with outcome in geriatric patients with TBI.

NCT ID: NCT05163262 Recruiting - Clinical trials for Traumatic Brain Injury

Descriptive and Prospective Study of Sphincter Disorders in the Severe Traumatic Brain Injury Population

TCG
Start date: February 2, 2022
Phase: N/A
Study type: Interventional

Severe traumatic brain injury (TCI), defined by an initial GCS of ≤ 8 and/or admitted to a neurosurgical intensive care unit, are responsible for diffuse brain lesions that can lead to multiple deficits, including impairment of sphincter functions: bladder, rectal and sexual. Bladder-sphincter disorders are very common after a TBI. Urinary incontinence predominates, with a prevalence varying from 50 to 100% in the acute period following a TBI. The variability of the clinical data is explained by the heterogeneity of the populations studied (severity of TBI, duration of coma, time to care) and the tools used to objectify sphincter disorders. The interest of this study is to make an evaluation and a prospective follow-up of sphincter disorders in this population during one year.

NCT ID: NCT05160194 Completed - Clinical trials for Traumatic Brain Injury

Gaining Real-Life Skills Over the Web

GROW
Start date: September 30, 2017
Phase: N/A
Study type: Interventional

Gaining Real-life Skills Over the Web (GROW) is an online parenting-skills intervention for caregivers of children aged 0-4 who sustained traumatic brain injuries. GROW is designed to promote family and child coping and adjustment for caregivers.

NCT ID: NCT05155800 Completed - Clinical trials for Traumatic Brain Injury

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

Sense-005
Start date: December 28, 2021
Phase:
Study type: Observational

The study population will consist of 3 mutually-exclusive sets of patients and subjects: - TBI patients with intracranial bleeding - TBI patients without intracranial bleeding - Control subjects with normal brain health. Research subjects between the ages of 22 to 50 will be enrolled. All TBI patients must have a diagnostic head CT scan within 24 hours of the injury. TBI patients without intracranial bleeding based on the CT scan must have a Glasgow Coma Scale (GCS) score at enrollment of ≤ 14. Total maximum duration of active monitoring with the device in this study is 48 hours with a clinical follow-up at day 7 after enrollment.

NCT ID: NCT05151978 Recruiting - Trauma, Brain Clinical Trials

Transcranial Doppler in Mild and Moderate Traumatic Brain Injury (TBI)

Start date: June 3, 2021
Phase:
Study type: Observational

Utility of transcranial Doppler as an Early Predictor of Neurological deterioration in Mild and Moderate Traumatic Brain Injury

NCT ID: NCT05151497 Recruiting - Brain-injury Clinical Trials

Effectiveness of Aquatic Theraphy in Spasticity: Watsu and Halliwick

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

Treatment with ACD patients will be carried out through the application of aquatic therapies, being the Halliwick Concept and the Watsu Method together with a time of immersion in hot water.